| 1650 |
National Cancer Institute |
Html |
en |
Selected Vegetables/Sun's Soup (PDQ®)–Patient Version |
Expert-reviewed information summary about the use of selected vegetables/Sun's soup as a treatment for people with cancer. Note: The information in this summary is no longer being updated and is provided for reference purposes only. |
| treatment | 0.620935 |
| cancer treatment | 0.517212 |
| cancer prevention | 0.486935 |
| Complementary Therapies Editorial | 0.534234 |
| United States | 0.494682 |
| Well-designed clinical trials | 0.477309 |
| Drug Administration | 0.522277 |
| Cancer Information Specialist | 0.498157 |
| cancer cells | 0.558873 |
| Cancer Information Service | 0.567973 |
| PDQ cancer information | 0.645069 |
| Cancer Complementary | 0.510973 |
| PDQ Selected Vegetables/Sun | 0.52487 |
| Vegetables/Sun’s Soup | 0.718967 |
| CAM therapies | 0.498393 |
| Soup ingredients | 0.49536 |
| treatment clinical trials | 0.493338 |
| National Cancer Institute | 0.676034 |
| clinical trials | 0.788657 |
| alternative medicine | 0.562862 |
| standard food | 0.487423 |
| conventional treatment | 0.48119 |
| cancer information summary | 0.571239 |
| alternative cancer therapies | 0.505071 |
|
| Federal Trade Commission | 0.49349 |
| National Institutes | 0.486354 |
| clinical trial | 0.532528 |
| new treatment | 0.541852 |
| mung bean | 0.494966 |
| CAM cancer research | 0.493212 |
| breast cancer prevention | 0.484457 |
| shiitake mushroom | 0.517658 |
| patients | 0.594168 |
| cancer patients | 0.547142 |
| new treatment works | 0.477537 |
| Cancer Care page | 0.486585 |
| health | 0.482953 |
| Selected Vegetables/Sun | 0.982781 |
| PDQ summary | 0.47773 |
| non-small cell lung | 0.519358 |
| NCI PDQ cancer | 0.530378 |
| cancer information database | 0.505237 |
| cell lung cancer | 0.547396 |
| alternative therapies | 0.532329 |
| cancer information summaries | 0.505491 |
| Frozen Selected Vegetables | 0.492972 |
| Therapies Editorial Board | 0.515019 |
|
CLICK HERE |
| 1714 |
National Cancer Institute |
Html |
en |
Computed Tomography (CT) Scans and Cancer |
A fact sheet that describes the CT scan procedure and technology and its uses in screening, diagnosis, and treatment. |
| CT imaging technology | 0.569562 |
| regular-dose CT scan | 0.562007 |
| lung cancer screening | 0.54026 |
| CT procedure | 0.731231 |
| newest CT scanners | 0.587346 |
| whole-body CT | 0.57001 |
| ct exams | 0.558916 |
| CT procedures | 0.54984 |
| lung cancer | 0.592986 |
| radiation dose | 0.50377 |
| health care providers | 0.544231 |
| multislice CT | 0.569592 |
| U.S. Food | 0.504864 |
| Lung Screening Trial | 0.488364 |
| single CT scan | 0.559043 |
| ct colonography | 0.665422 |
| colorectal cancer | 0.498955 |
| older CT techniques | 0.588973 |
| Tracking radiation exposure | 0.48666 |
| multiple CT scans | 0.560065 |
| standard CT | 0.559346 |
| National CT Colonography | 0.621292 |
| helical CT procedure | 0.596247 |
| low-dose CT scan | 0.568401 |
|
| average annual dose | 0.483921 |
| CT scanner manufacturers | 0.553452 |
| CT scans | 0.582194 |
| low-dose helical CT | 0.69526 |
| radiation risks | 0.502098 |
| Drug Administration | 0.507156 |
| radiation exposure | 0.603574 |
| modern CT machines | 0.590707 |
| American College | 0.525134 |
| original CT machines | 0.590542 |
| CT imaging | 0.587843 |
| National Lung Screening | 0.489052 |
| external-beam radiation therapy | 0.487398 |
| people | 0.506505 |
| natural background radiation | 0.502791 |
| CT | 0.922359 |
| radiation dose exposures | 0.484749 |
| radiation | 0.608408 |
| Unnecessary Radiation Exposure | 0.486946 |
| cancer risk | 0.502536 |
| cancer | 0.609695 |
| CT scanners | 0.63294 |
| multidetector CT scanners | 0.588732 |
| typical CT procedure | 0.581742 |
|
CLICK HERE |
| 1963 |
National Cancer Institute |
Html |
es |
Tratamiento del carcinoma de células de Merkel (PDQ®)–Versión para pacientes |
Resumen de información revisada por expertos acerca del tratamiento del carcinoma de células de Merkel. |
| siguientes procedimientos | 0.69003 |
| estadio iv | 0.713668 |
| siguientes aspectos | 0.637912 |
| ganglio linfático centinela | 0.981847 |
| vÃa oral | 0.618977 |
| rayos x | 0.627438 |
| estadio ib | 0.770198 |
| Merkel causa efectos | 0.682552 |
| estadio ia | 0.76846 |
| escáner tep | 0.628975 |
| luz solar | 0.628063 |
| National Cancer Institute | 0.617139 |
| siguientes riesgos | 0.613115 |
|
| ganglios linfáticos.ampliar biopsia | 0.728335 |
| nota cambios | 0.628407 |
| Instituto Nacional | 0.631866 |
| estadio iiia | 0.644166 |
| PDQ Tratamiento | 0.631004 |
| estadio iia | 0.644928 |
| estadio iic | 0.644457 |
| Physician Data Query | 0.665687 |
| último panel | 0.626069 |
| siguientes caracterÃsticas | 0.637587 |
| siguientes pruebas | 0.688976 |
| radiación ultravioleta | 0.629465 |
| siguientes estadios | 0.630948 |
|
CLICK HERE |
| 1983 |
National Cancer Institute |
Html |
es |
Tratamiento de los tumores embrionarios del sistema nervioso central infantil (PDQ®)–Versión para profesionales de salud |
Resumen de información revisada por expertos acerca del tratamiento del meduloblastoma infantil, los tumores embrionarios distintos del meduloblastoma y los tumores pineales infantiles. |
| meduloblastoma wnt | 0.448042 |
| primitive neuroectodermal tumors | 0.463972 |
| Kool M | 0.408951 |
| tumores wnt | 0.418547 |
| prognostic factors | 0.423834 |
| germline mutations | 0.4087 |
| with medulloblastoma harboring | 0.411601 |
| with medulloblastoma receiving | 0.411471 |
| early childhood medulloblastoma | 0.42493 |
| childhood medulloblastoma | 0.434401 |
| meduloblastomas shh | 0.413706 |
| Rutkowski S | 0.412968 |
| Clin Pract Oncol | 0.409953 |
| with carboplatin | 0.411606 |
| with localized medulloblastoma | 0.410611 |
| Natl Cancer Inst | 0.412552 |
| vÃa wnt | 0.411172 |
| with retinoblastoma during | 0.417144 |
| Medulloblastoma with extensive | 0.410624 |
| Acta Neuropathol | 0.421932 |
| Boyett JM | 0.420388 |
| Children's Cancer | 0.444511 |
| Lancet Oncol | 0.408704 |
| medulloblastoma subtypes with | 0.411732 |
| subtipo shh | 0.409562 |
|
| meduloblastomas wnt | 0.413294 |
| Remke M | 0.416131 |
| tumores shh | 0.419097 |
| Neuro Oncol | 0.413263 |
| Pediatr Blood Cancer | 0.465506 |
| Childrens Cancer Group | 0.412973 |
| neuroectodermal tumors treated | 0.41729 |
| with medulloblastoma | 0.429537 |
| Med Genet | 0.409674 |
| Clin Oncol | 0.618048 |
| sistema nervioso central | 0.455844 |
| with supratentorial primitive | 0.416554 |
| pediatric medulloblastoma | 0.410979 |
| Children's Cancer Group | 0.43162 |
| von hoff k | 0.413579 |
| tumors treated with | 0.41728 |
| término tumor | 0.409479 |
| tumores embrionarios | 0.947028 |
| Kingdom Children Cancer | 0.420872 |
| vÃa shh | 0.424313 |
| children's oncology group | 0.440874 |
| Children's Cancer Study | 0.422483 |
| molecular subgroups | 0.410404 |
| Cancer Study Group | 0.41491 |
|
CLICK HERE |
| 2040 |
National Cancer Institute |
Html |
es |
Exámenes de detección del cáncer de piel (PDQ®)–Versión para pacientes |
Resumen de información revisada por expertos acerca de las pruebas que se utilizan para detectar sistemáticamente el cáncer de piel. |
| antecedentes familiares | 0.452736 |
| nevo atÃpico | 0.361408 |
| almacena agua | 0.367337 |
| lámparas solares | 0.360685 |
| PDQ Exámenes | 0.39849 |
| Physician Data Query | 0.505569 |
| mayores probabilidades | 0.363001 |
| radiación uv | 0.621972 |
| Estados Unidos | 0.932757 |
| simple vista | 0.348992 |
| prevención revisa | 0.335498 |
| Skin Cancer | 0.36265 |
|
| siguientes ejemplos | 0.362131 |
| luz solar | 0.675106 |
| información ayuda | 0.338156 |
| vitamina d | 0.367339 |
| CaracterÃsticas genéticas | 0.361581 |
| National Cancer Institute | 0.353374 |
| siguientes riesgos | 0.336165 |
| piel melanoma | 0.814223 |
| radiación ultravioleta | 0.507855 |
| siguientes sumarios | 0.40536 |
| Instituto Nacional | 0.399902 |
|
CLICK HERE |
| 3453 |
National Cancer Institute |
Html |
es |
Planificar la transición para la atención del cáncer avanzado en la etapa final de la vida (PDQ®)–Versión para profesionales de salud |
Resumen de información revisada por expertos sobre la preparación necesaria por parte de los proveedores de atención de la salud, los pacientes y sus familias para la transición a la atención del cáncer avanzado en la etapa final de la vida. |
| health care spending | 0.331274 |
| Zimmermann C | 0.347816 |
| Burman D | 0.32527 |
| posibles factores | 0.333049 |
| Ewer MS | 0.322761 |
| cancer care near | 0.391306 |
| creciente número | 0.323261 |
| Sin embargo | 0.941022 |
| American Cancer Society | 0.434589 |
| etapa efv | 0.333862 |
| Health Care Brief | 0.329424 |
| fase ii | 0.322051 |
| Swami N | 0.348223 |
| care providers | 0.323463 |
| intensive care unit | 0.365314 |
| Cancer Care Outcomes | 0.349727 |
| coping with cancer | 0.340049 |
| quimioterapia paliativa | 0.367064 |
| cancer care | 0.411213 |
| Early palliative care | 0.33009 |
| Landrum MB | 0.323564 |
| Dartmouth Institute | 0.324797 |
| Estados Unidos | 0.323783 |
| Support Care | 0.43154 |
| mayores gastos | 0.34678 |
|
| Med Care | 0.326126 |
| patients with | 0.439314 |
| end-of-life care | 0.465368 |
| good death | 0.325189 |
| Care Cancer | 0.418414 |
| Cancer Facts | 0.334548 |
| fase i | 0.325785 |
| palliative care | 0.349857 |
| cardiac arrest | 0.325245 |
| Dartmouth Atlas | 0.325161 |
| ill patients with | 0.328355 |
| cardiopulmonary resuscitation | 0.351378 |
| medical intensive care | 0.329231 |
| care intensity | 0.323054 |
| beneficiaries dying with | 0.321915 |
| Clinical Practice | 0.32872 |
| forma favorable calidad | 0.324109 |
| alta calidad | 0.387852 |
| Health Policy | 0.327199 |
| health care | 0.342416 |
| Intern Med | 0.355877 |
| Clin Oncol | 0.402042 |
| Arch Intern Med | 0.354168 |
| respiración mecánica | 0.42963 |
|
CLICK HERE |
| 3456 |
National Cancer Institute |
Html |
es |
Acupuntura (PDQ®)–Versión para pacientes |
Resumen de información revisada por expertos sobre la acupuntura como tratamiento para las personas con cáncer o trastornos relacionados con esta enfermedad. |
| acupuntura forma | 0.644774 |
| Centro Nacional | 0.425173 |
| causa reacciones | 0.422733 |
| New Hampshire Avenue | 0.41766 |
| acupuntos correctos | 0.426568 |
| causa hinchazón | 0.417784 |
| Drug Administration | 0.410869 |
| neuropatÃa periférica | 0.548649 |
| NCI Best Case | 0.428652 |
| datos bibliográficos pubmed | 0.418907 |
| largo plazo | 0.414083 |
| National Cancer Institute | 0.420958 |
| siglo xviii | 0.41833 |
| siguientes riesgos | 0.413128 |
| PDQ Acupuntura | 0.568448 |
| acupuntura ayuda | 0.53948 |
| Instituto Nacional | 0.496395 |
| numerosos informes | 0.41497 |
| National Certification Commission | 0.424144 |
| Salud Complementaria | 0.436282 |
| Visuals Online | 0.412814 |
|
| náuseas matutinas | 0.436773 |
| mamaEl linfedema | 0.418357 |
| complementarias revisa | 0.41658 |
| sistema nervioso central | 0.511178 |
| Physician Data Query | 0.473664 |
| Medicina Oriental | 0.41709 |
| Estados Unidos | 0.901304 |
| Comisión Nacional | 0.410413 |
| libre uso | 0.418723 |
| Oriental Medicine | 0.412484 |
| distintos resultados | 0.413109 |
| cabo estudios | 0.47129 |
| piel agujas | 0.436066 |
| página manejo | 0.412054 |
| ¿El tratamiento | 0.424697 |
| ¿Los beneficios | 0.410887 |
| juntos cam | 0.410417 |
| qi causa dolor | 0.459263 |
| Series Program | 0.410794 |
| medicina complementaria | 0.788071 |
| Institutos Nacionales | 0.521236 |
|
CLICK HERE |
| 3519 |
National Cancer Institute |
Html |
en |
Research Team Members |
Information about the different types of experts involved in designing and running a clinical trial. |
| treatment | 0.240173 |
| Typical team members | 0.477277 |
| data management | 0.339957 |
| records | 0.222317 |
| Staff physician | 0.322575 |
| concept | 0.2227 |
| aspects | 0.224933 |
| Institutional Review Board | 0.455886 |
| study monitoring | 0.329306 |
| Treats patients | 0.324814 |
| skills | 0.22687 |
| presentation | 0.223824 |
| Supervises data collection | 0.479065 |
| responsibilities | 0.228481 |
| recruitment | 0.225467 |
| course | 0.246736 |
| health care providers | 0.443729 |
| Works | 0.240321 |
| audits | 0.222243 |
|
| research nurse | 0.569926 |
| final data analysis | 0.435286 |
| clinical trial | 0.945844 |
| Provides data | 0.334954 |
| approval | 0.227398 |
| different sites | 0.354975 |
| monitoring agencies | 0.324055 |
| Assesses | 0.227864 |
| Data manager | 0.339195 |
| different types | 0.351452 |
| Communicates | 0.231534 |
| principal investigator | 0.901171 |
| person | 0.339796 |
| quality assurance | 0.332626 |
| Educates staff | 0.334468 |
| IRB | 0.235474 |
| Designing | 0.224461 |
| informed consent process | 0.715664 |
| experts | 0.226806 |
|
CLICK HERE |
| 3935 |
National Cancer Institute |
Html |
es |
Cáncer recurrente: cáncer que regresa |
El cáncer puede regresar cuando el tratamiento no elimina o destruye por completo todas las células cancerosas. Aprenda acerca de los diferentes tipos de recurrencia -recidiva- y cómo se vuelve a asignar un estadio al cáncer y se da tratamiento. |
|
|
CLICK HERE |
| 16711 |
National Cancer Institute |
Html |
null |
Iniciativa de Respuestas Excepcionales: Preguntas y respuestas |
El Instituto Nacional del Cáncer (NCI) emprendió la Iniciativa de Respuestas Excepcionales a fin de entender la base molecular de los tumores en pacientes de cáncer que responden en forma excepcional al tratamiento, principalmente quimioterapia. |
|
|
CLICK HERE |